US Patent 8187877 Chronic lymphocytic leukemia cell line
Patent 8187877 was granted and assigned to Alexion Pharmaceuticals, Inc. on May, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+315 characters)
Article
Patent abstract
The preparation and characterization of antibodies that bind to antigens on CLL or other cancer cells, especially to antigens upregulated in the cancer cells, and the identification and characterization of antigens present on or upregulated by cancer cells are useful in studying and treating cancer.
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
John McWhirter0
Katherine S. Bowdish0
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08187877 Chronic lymphocytic leukemia cell line US Patent 8187877 Chronic lymphocytic leukemia cell line
Infobox
Patent Number
081878770
Patent Number
81878770
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
081878770
Date of Patent
May 29, 2012
0Patent Application Number
122867590
Date Filed
September 30, 2008
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08187877 Chronic lymphocytic leukemia cell line
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08187877
Date of patent
May 29, 2012
Patent application number
12286759
Date Filed
September 30, 2008
Patent primary examiner
Find more entities like US Patent 8187877 Chronic lymphocytic leukemia cell line
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
